Table 1.
Participant demographics.
| Participant | Age | Sex | Time since PD Onset (yr) | Hoehn and Yahr Stage |
UPDRS Total Score | Parkinson's Subtype | Fall history (baseline) | MOCA | Parkinson's Medications | Activity Level | Freezer vs. Non-Freezer |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 60 | M | 13 | 3 | 65 | I | 2+ | 28 | Amantadine, Sinemet, Pramipexole, Inbrija, Entacapone | Sedentary | Fr |
| 2 | 66 | M | 0.75 | 1.5 | 22 | TD | 0 | 30 | None | Sedentary | NFr |
| 3 | 69 | M | 1 | 2 | 26 | PIGD | 0 | 29 | Sinemet | Active | NFr |
| 4 | 80 | M | 1.5 | 3 | 30.5 | PIGD | 2+ | 22a | Sinemet | Mildly Active | Fr |
| 5 | 74 | M | 5 | 2 | 43.5 | TD | 2+ | 29 | Sinemet | Active | Fr |
| 6 | 68 | M | 6 | 3 | 86.5 | PIGD | 2 | 24a | Sinemet | Active | Fr |
| 7 | 64 | F | 5.25 | 1.5 | 26 | PIGD | 0 | 26 | Sinemet | Active | NFr |
| 8 | 72 | F | 5 | 3 | 24 | PIGD | 0 | 28 | Pramipexole, Sinemet | Sedentary | NFr |
| 9 | 62 | M | 3.75 | 2 | 41 | I | 1 | 26 | Sinemet | Active | NFr |
| 10 | 46 | F | 3.75 | 2 | 47.5 | PIGD | 0 | 26 | Sinemet, Mirapex | Active | NFr |
| 11 | 82 | F | 3.75 | 3 | 47 | PIGD | 1 | 27 | Sinemet, Carbidopa | Sedentary | NFr |
| 12 | 63 | M | 5 | 2 | 58 | TD | 0 | 28 | Sinemet | Active | Fr |
a
= suggests mild cognitive impairment; UPDRS, Unified Parkinson's Disease Rating Scale; Sedentary, no reported activity prior to study; Mildly active, 30 min of exercise less than three days weekly; Active, >30 min of exercise three or more days weekly; M, Male, F, Female, Bolded fall data, injurious fall; Fr, Freezer; NFr, Non-Freezer; TD, PD Subtype (79): Tremor Dominant; PIGD, Postural Instability and Gait Disturbance; I, Indeterminate.